{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:50:12Z","timestamp":1786373412873,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.2215\/cjn.00180115","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T22:44:22Z","timestamp":1439937862000},"page":"1575-1584","source":"Crossref","is-referenced-by-count":26,"title":["Lifetime Risk of Stage 3\u20135 CKD in a Community-Based Sample in Iceland"],"prefix":"10.2215","volume":"10","author":[{"given":"Lesley A.","family":"Inker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocine","family":"Tighiouart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Aspelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur S.","family":"Indridason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runolfur","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Shastri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20230601","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R2-12-20230601","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.","volume":"79","author":"van der Velde","year":"2011","journal-title":"Kidney Int"},{"key":"R3-12-20230601","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"R4-12-20230601","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"R5-12-20230601","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis.","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"R6-12-20230601","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ahj.2013.03.016","article-title":"Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States.","volume":"166","author":"Foster","year":"2013","journal-title":"Am Heart J"},{"key":"R7-12-20230601","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/archinte.168.20.2268","article-title":"Patient awareness of chronic kidney disease: Trends and predictors.","volume":"168","author":"Plantinga","year":"2008","journal-title":"Arch Intern Med"},{"key":"R8-12-20230601","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R9-12-20230601","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1053\/j.ajkd.2013.03.009","article-title":"Lifetime incidence of CKD stages 3-5 in the United States.","volume":"62","author":"Grams","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R10-12-20230601","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jama.2013.285141","article-title":"Risk of end-stage renal disease following live kidney donation.","volume":"311","author":"Muzaale","year":"2014","journal-title":"JAMA"},{"key":"R11-12-20230601","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: A simulation model for the CDC CKD Initiative.","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R12-12-20230601","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-122-2-199501150-00003","article-title":"Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.","volume":"122","author":"Sigurdsson","year":"1995","journal-title":"Ann Intern Med"},{"key":"R13-12-20230601","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwk115","article-title":"Age, Gene\/Environment Susceptibility-Reykjavik Study: Multidisciplinary applied phenomics.","volume":"165","author":"Harris","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R14-12-20230601","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/ndt\/gfh914","article-title":"Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.","volume":"20","author":"Viktorsdottir","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R15-12-20230601","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"R16-12-20230601","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1495::AID-SIM441>3.0.CO;2-E","article-title":"Computing estimates of incidence, including lifetime risk: Alzheimer\u2019s disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.","volume":"19","author":"Beiser","year":"2000","journal-title":"Stat Med"},{"key":"R18-12-20230601","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States.","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"R19-12-20230601","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(98)10279-9","article-title":"Lifetime risk of developing coronary heart disease.","volume":"353","author":"Lloyd-Jones","year":"1999","journal-title":"Lancet"},{"key":"R20-12-20230601","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: A meta-analysis of 37 randomized controlled trials.","volume":"64","author":"Lambers Heerspink","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R21-12-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/j.ajkd.2010.02.339","article-title":"Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).","volume":"55","author":"Manns","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R22-12-20230601","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2010.10.007","article-title":"US Renal Data System 2010 Annual Data Report.","volume":"57","author":"Collins","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R23-12-20230601","doi-asserted-by":"crossref","first-page":"f324","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis.","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ"},{"key":"R24-12-20230601","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/ndt\/gfr003","article-title":"Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population.","volume":"26","author":"van den Brand","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R26-12-20230601","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/sj.ki.5002374","article-title":"Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study.","volume":"72","author":"Wetzels","year":"2007","journal-title":"Kidney Int"},{"key":"R28-12-20230601","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2215\/CJN.08070811","article-title":"Serum fibroblast growth factor-23 and risk of incident chronic kidney disease in older community-dwelling women.","volume":"7","author":"Semba","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-12-20230601","first-page":"419","article-title":"Ageing and the glomerular filtration rate: Truths and consequences.","volume":"120","author":"Glassock","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R30-12-20230601","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/ndt\/gfs265","article-title":"Normal reference values for glomerular filtration rate: What do we really know?","volume":"27","author":"Delanaye","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R31-12-20230601","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ndt\/gft306","article-title":"Con: Thresholds to define chronic kidney disease should not be age dependent.","volume":"29","author":"Glassock","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R32-12-20230601","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2012.16817","article-title":"Age and association of kidney measures with mortality and end-stage renal disease.","volume":"308","author":"Hallan","year":"2012","journal-title":"JAMA"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201509000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:41Z","timestamp":1786369541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201509000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00180115","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}